IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: A potential role in psoriasis

European Journal of Immunology

Volumn 36, Issue 5, 2006, Pages 1309-1323

  Wolk, Kerstin ^a   Witte, Ellen ^a   Wallace, Elizabeth ^a   Döcke, Wolf Dietrich ^b   Kunz, Stefanie ^a   Asadullah, Khusru ^b   Volk, Hans Dieter ^a   Sterry, Wolfman ^a   Sabat, Robert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

CALML; IL 19 Psoriasin; IL 20

Indexed keywords

CALGRANULIN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; DESMOCOLLIN; GAMMA INTERFERON; INTERLEUKIN 22; INTERSTITIAL COLLAGENASE; KALLIKREIN; KERATIN; PROFILAGGRIN; PSORIASIN; STROMELYSIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; KERATINOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PSORIASIS; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN EPITHELIUM; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; CALGRANULIN A; CALGRANULIN B; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKINS; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED BALB C; PSORIASIS;

EID: 33646552450     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535503     Document Type: Article

References (52)

1. Dumouder, L., Louahed, J. and Renauld, J. C., Cloning and characterization of IL- 10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 2000. 164: 1814-1819.
2. Xie, M. H., Aggarwal, S., Ho, W. H., Foster, J., Zhang, Z., Stinson, J., Wood, W. I. et al., Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 2000. 275: 31335-31339.
3. Donnelly, R. P., Sheikh, F., Kotenko, S. V. and Dickensheets, H., The expanded family of class II cytokines that share the EL-10 receptor-2 (IL-1OR2) chain. J. Leukoc. Biol. 2004. 76: 314-321.
4. Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y. and Fisher, P. B., Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004. 22: 929-979.
5. Volk, H., Asadullah, K., Gallagher, G., Sabat, R. and Gratz, G., M-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol. 2001. 22: 414-417.
6. Dumoutier, L., Van Roost, E., Arneye, G., Michaux, L. and Renauld, J. C., IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 2000. 1: 488-494.
7. Wolk K., Kunz, S., Asadullah, K., and Sabat, R., Cutting edge: immune cells as sources and targets of the EL-10 family members? J. Immunol. 2002. 168: 5397-5402.
8. Dumoutier, L., Van Roost, E., Colau, D. and Renauld, J. C., Human interleukin- 10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. & Sci. USA 2000. 97: 10144-10149.
9. Kotenko, S. V., Izotova, L. S., Mirochnitcheriko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P. and Pestka, S., Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-1ORbeta) is a common chain of both the IL-10 and IL-22 (EL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 2001. 276: 2725-2732.
10. Wolk K., Witte, E., Reineke, U., Witte, K., Friedrich, M., Sterry, W., Asadullah, K. et al., Is there an interaction between interleukin-10 and interleukin-22? Genes Immun. 2005. 6: 8-18.
11. Lejeune, D., Dumoutier, L., Constantinescu, S., Kruijer, W., Schuringa, J. J. and Renauld, J. C., Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 2002. 277: 33676-33682.
12. Dumoutier, L., Lejeune, D., Colau, D. and Renauld, J. C., Cloning and characterization of IL-22 binding protein, a natural antagonist of EL-10-related T cell-derived inducible factor/IL-22. J. Immunol. 2001. 166: 7090-7095.
13. Kotenko, S. V., Izotova, L. S., Mirochnitchenko, O. V., Esterova, E., Dickensheets, H., Donnelly, R. P. and Pestka, S., Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 2001. 166: 7096-7103.
14. Xu, W., Presnell, S. &, Parrish-Novak, J., Kindsvogel, W., Jaspers, S., Chen, Z., Dillon, S. R. et al., A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl. Acacl. Sci. USA 2001. 98: 9511-9516.
15. Gruenberg, B. H., Schoenemeyer, A., Weiss, B., Toschi, L., Kunz, S., Wolk, K., Asadullah, K., and Sabat, R., A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun. 2001. 2: 329-334.
16. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, YL and Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 2004. 21: 241-254.
17. Aggarwal, S., Xie, M. H., Maruoka, M., Foster, J. and Gurney, A. L, Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 2001. 21: 1047-1053.
18. Radaeva, S., Sun, R, Pan, H. N., Hong, F. and Gao, B., Interleukin 22 (IL-22) plays a protective role in T cell-mediated marine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004. 39: 1332-1342.
19. Whittington, H. A., Armstrong, L., Uppington, K. M. and Millar, A. B., Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell. Mol. Biol. 2004. 31: 220-226.
20. Nagalakshmi, M. L., Rascle, A., Zurawski, S., Menon, S. and de Waal Malefyt R., Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 2004. 4: 679-691.
21. Lew, W., Bowcock, A. M. and Krueger, J. G., Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. Trends Immunol. 2004. 25: 295-305.
22. Pilcher, B. K., Dumin, J., Schwartz, M. J., Mast B. A., Schultz, G. S., Parks, W. C. and Welgus, H. G., Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J. Biol. Chem. 1999. 274: 10372-10381.
23. Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J. et al., Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 2002. 277: 12838-12845.
24. Glaser, R., Harder, J., Lange, H., Bartels, J., Christophers, E. and Schroder, J. M., Antimicrobial psoriasin (S1OOA7) protects human skin from Escherichia coli infection. Nat. Immunol. 2005. 6: 57-64.
25. 2+-binding proteins S1OOA8 and S10OA9 are encoded by novel injury-regulated genes. J. Biol. Chem. 2001. 276: 35818-35825.
26. Harder, J. and Schroder, J. M., Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol. 2005. 77: 476-486.
27. Fuchs, E., Epidermal differentiation: the bare essentials. J. Cell Biol. 1990. 111: 2807-2814.
28. Pearton, D. J., Dale, B. A. and Presland, R. B., Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J. Invest. Dermatol. 2002. 119: 661-669.
29. Kuechle, M. K., Thulin, C. D., Presland, R. B. and Dale, B. A., Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo. J. Invest. Dermatol. 1999. 112: 843-852.
30. Porter, R. M., Leitgeb, S., Melton, D. W., Swensson, O., Eady, R. A. and Magin, T. M., Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J. Cell Biol. 1996. 132: 925-936.
31. Mehul, B., Bernard, D., Simonetti, L., Bernard, M. A. and Schmidt, R., Identification and cloning of a new calmodulin-like protein from human epidermis. J. Biol. Chem. 2000. 275: 12841-12847.
32. Fuchs, E. and Weber, K., Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 1994. 63: 345-382.
33. Fuchs, E., Keratins and the skin. Annu. Rev. Cell Dev. Biol. 1995. 11: 123-153.
34. Oomizu, S., Sahuc, F., Asahina, V, Inamatsu, M., Matsuzaki T., Sasaki, M., Obara, M. and Yoshizato, K., Kdap, a novel gene associated with the stratification of the epithelium. Gene 2000. 256: 19-27
35. Caubet C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T. et al., Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/ hK7. J. Invest. Dermatol. 2004. 122: 1235-1244.
36. Franzke, C. W., Baici A., Bartels, J., Christophers, E. and Wiedow, O., Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J. Biol. Chem. 1996. 271: 21886-21890.
37. Nagase, H. and Woessner, J. F. Jr., Matrix metalloproteinases. J. Biol. Chem. 1999. 274: 21491-21494.
38. Pilcher, B. K., Dumin, J. A., Sudbeck B. D., Krane, S. M., Welgus, H. G. and Parks, W. C., The activity of collagenase-1 is required for keratinocyte migration on a type 1 collagen matrix. J. Cell Biol. 1997. 137: 1445-1457
39. Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K. et al., Keratinocyte-specific ablation of Stat:3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999. 18: 4657-4668.
40. Bullard, K M., Lund, L., Mudgett, J. S., Mellin, T. N., Hunt, T. K., Murphy, B., Ronan, J. et al., Impaired wound contraction in stromelysin-1-deficient mice. Ann. Surg. 1999. 230: 260-265.
41. Li, C. K, Pender, S. L., Pickard, K. M., Chance, V., Holloway, J. A., Huett, A., Goncalves, N. S. et al., Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J. Immunol. 2004. 173: 5171-5179.
42. 2+ -dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J. Cell Biol. 1997. 138: 193-201.
43. Goebeler, V., Rube, D., Gerke, V. and Rescher, U., Atypical properties displayed by annexin A9, a novel member of the annexin family of Ca(2+) and lipid binding proteins. FEBS Lett. 2003. 546: 359-364.
44. Hayes, M. J., Rescher, U., Gerke, V. and Moss, S. E., Annexin-actin interactions. Traffic 2004. 5: 571-576.
45. Boniface, K., Bernard, F. X, Garcia, M., Gurney, A. L, Lecron, J. C. and Morel, F., IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 2005. 174: 3695-3702.
46. Jinquan, T., Vorum, H., Larsen, C. G., Madsen, P., Rasmussen, H. H., Gesser, B., Etzerodt, M. et al., Psoriasin: a novel chemotactic protein. J. Invest. Dermatol. 1996. 107: 5-10.
47. Blumberg, H., Conklin, D., Xu, W. F., Grossmann, A., Brender, T., Carollo, S., Eagan, M. et al., Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 2001. 104: 9-19.
48. Renauld, J. C., Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 2003. 3: 667-676.
49. Weiss, B., Wolk, K., Grunberg, B. H., Volk H. D., Sterry, W., Asadullah, K., and Sabat, R., Cloning of routine IL-22 receptor alpha 2 and comparison with its human counterpart. Genes Immun. 2004. 5: 330-336.
50. Liu, A. Y., Destoumieux, D., Wong, A. V., Park C. H., Valore, E. V., Liu, L. and Ganz, T., Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Invest. Dermatol. 2002. 118: 275-281.
51. Wolk K., Docke, W. D., von Baehr, V., Volk H. D. and Sabat, R., Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000. 96: 218-223.
52. Wolk, K., Kunz, S., Crompton, N. E., Volk, H. D. and Sabat, R., Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J. Biol. Chem. 2003. 278: 18030-18036.